Mast Cell Activation Syndrome Update—A Dermatological Perspective
Journal of Personalized Medicine · 10.07.2023 · 13 (7) · 1116
DOI: 10.3390/jpm13071116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.07.2023. Verfasst von Dana Mihaela Mihele und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mast cells (MCs) are infamous for their role in potentially fatal anaphylaxis reactions. In the last two decades, a more complex picture has emerged, as it has become obvious that MCs are much more than just IgE effectors of anaphylaxis. MCs are defenders against a host of infectious and toxic aggressions (their interactions with other components of the immune system are not yet fully understood) and after the insult has ended, MCs continue to play a role in inflammation regulation and tissue repair. Unfortunately, MC involvement in pathology is also significant. Apart from their role in allergies, MCs can proliferate clonally to produce systemic mastocytosis. They have also been implicated in excessive fibrosis, keloid scaring, graft rejection and chronic inflammation, especially at the level of the skin and gut. In recent years, the term MC activation syndrome (MCAS) was proposed to account for symptoms caused by MC activation, and clear diagnostic criteria have been defined. However, not all authors agree with these criteria, as some find them too restrictive, potentially leaving much of the MC-related pathology unaccounted for. Here, we review the current knowledge on the physiological and pathological roles of MCs, with a dermatological emphasis, and discuss the MCAS classification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania.
- Dermatology Department, Victor Babes Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania.
- Internal Medicine Department, Emergency University Hospital Bucharest, 169 Independence Blvd, 050098 Bucharest, Romania.
- Microbiology Department, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania.
- Fetal Medicine Excellence Research Center, Alessandrescu-Rusescu National Institute for Mother and Child Health, 020395 Bucharest, Romania.
- Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania.
ORCID-Profile: Mircea Tampa
Zitieren
APA
Mihele, D. M., Nistor, P. A., Bruma, G., Mitran, C. I., Mitran, M. I., Condrat, C. E., Tovaru, M., Tampa, M., & Georgescu, S. R. (2023). Mast Cell Activation Syndrome Update—A Dermatological Perspective. Journal of Personalized Medicine, 13(7), 1116. https://doi.org/10.3390/jpm13071116
Vancouver
Mihele DM, Nistor PA, Bruma G, Mitran CI, Mitran MI, Condrat CE, et al. Mast Cell Activation Syndrome Update—A Dermatological Perspective. Journal of Personalized Medicine. 2023;13(7):1116. doi:10.3390/jpm13071116
BibTeX
@article{Mihele2023,
author = {Mihele, Dana Mihaela and Nistor, Paul Andrei and Bruma, Gabriela and Mitran, Cristina Iulia and Mitran, Madalina Irina and Condrat, Carmen Elena and Tovaru, Mihaela and Tampa, Mircea and Georgescu, Simona Roxana},
title = {Mast Cell Activation Syndrome Update—A Dermatological Perspective},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {7},
pages = {1116},
doi = {10.3390/jpm13071116}
}
EUVIMED